Global In Vitro Diagnostics (IVD) Market Drivers, Opportunities, Trends and Forecasts 2014-2017 & 2020 - Research and Markets

DUBLIN--()--The "Global In Vitro Diagnostics (IVD) Market: Drivers, Opportunities, Trends and Forecasts: 2014 - 2020" report has been added to Research and Markets' offering.

The global in-vitro diagnostics market is estimated to witness a CAGR of 5.31% during the forecast period 2017-2023. The market is analyzed based on five segments - technology, application, test types, end-users, and regions.

Factors, such as increased sales of POC cardiac markers and increased adoption of DNA probe-based diagnostics are growth opportunities for the market players. The market is witnessing an emerging trend of companion diagnostics, cardiac biomarkers, POC markers, and other novel technologies that are helping in diagnosing the diseases at an early stage with precision. There has been a transition from diagnosis in core laboratories to diagnosis in front of the patient.

The markets in India, Brazil, and China are expected to grow at a rapid pace during the forecast period as the prevalence of infectious diseases and lifestyle diseases in these countries is high. These countries are set to be the target regions for the market players due to the large untapped potential.

The leader in IVD market is F. Hoffmann-La Roche, who is currently occupying 20% of the IVD market. Abbott, Siemens, Danaher, and ThermoFisher are the other major players in the market. These top players occupy around 56% of the market.

Key Topics Covered:

1 Industry Outlook

2 Report Outline

3 Market Snapshot

4 Market Outlook

5 Market Characteristics

6 By Technology: Market Size and Analysis

7 By Application: Market Size and Analysis

8 Test Types: Market Size and Analysis

9 End User: Market Size and Analysis

10 Regions: Market Size and Analysis

11 Competitive Landscape

12 Vendor Profiles

13 Companies to Watch For

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson and Company
  • BioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation.
  • F.Hoffmann-La Roche Ltd
  • Ortho Clinical Diagnostics (Carlyle Group)
  • Qiagen NV
  • Siemens Healthineers Inc.
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/research/48phfr/global_in_vitro

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics